Current Cancer Drug Targets

SCI SCIE

国际简称：CURR CANCER DRUG TAR 参考译名：当前的抗癌药物靶点

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约1月

《当前的抗癌药物靶点》(Current Cancer Drug Targets)是一本由Bentham Science Publishers B.V.出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q3 JCR分区
132 年发文量
2.5 IF影响因子
未开放 是否OA
85 H-index
2001 创刊年份
Bimonthly 出版周期
English 出版语言

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

[ 查看全部 ]

投稿咨询加急咨询

Current Cancer Drug Targets期刊信息

ISSN：1568-0096
出版语言：English
是否OA：未开放
E-ISSN：1873-5576
出版地区：NETHERLANDS
是否预警：否
出版商：Bentham Science Publishers B.V.
出版周期：Bimonthly
创刊时间：2001
开源占比：0.0095
Gold OA文章占比：8.03%
OA被引用占比：0
出版国人文章占比：0.27
出版撤稿占比：0
研究类文章占比：60.61%

Current Cancer Drug Targets CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.2

0.726

0.546

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q2	204 / 428	52%
大类：Medicine 小类：Pharmacology	Q3	174 / 328	47%
大类：Medicine 小类：Drug Discovery	Q3	94 / 161	41%
大类：Medicine 小类：Cancer Research	Q3	151 / 233	35%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Current Cancer Drug Targets中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ONCOLOGY 肿瘤学	4区

Current Cancer Drug Targets JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	204 / 333	38.9
学科：ONCOLOGY	SCIE	Q3	224 / 333	32.88

Current Cancer Drug Targets历年数据统计

影响因子

中科院分区

Current Cancer Drug Targets中国学者发文选摘

1、Exploration of the Synergistic Effect of Chitosan Oligosaccharide and Dacarbazine (DTIC) in the Treatment of Melanom
Author: Zhang, Xin; Chen, Wencui; Zhang, Keke; Liu, Zhende; Lyu, Qianqian; Jin, Liming; Liu, Weizhi

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096423297251202110111
2、In Silico Multi-omics Analyses of Kinesin Family Member 15 in Pan-Cancer and Validation in Tissue Microarra
Author: Xiang, Mengqin; Hu, Qing; Li, Yanchun; Wu, Hao

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096420482251130063549
3、Comparative Analysis of Homologous Recombination Repair Status Across Gynecologic and Breast Cancers in Chinese Population
Author: Huang, Yongsheng; Shao, Jiajia; Yin, Xinke; Jiang, Yuanling; Luo, Jiahuan; Huang, Jinghua; Zhao, Jianli; Fu, Sha; Liao, Jianwei

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096437832251215093401
4、NDUFA10: An Emerging Oncogenic Driver of Metastasis in Lung Adenocarcinom
Author: Hu, Tianqi; Chen, Yixin; Lu, Yi; He, Yuyu; Chou, Lunan; Fu, Jiali; Huang, Kate; Wang, Yumin; Chen, Jie

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096440556260123113410
5、A Novel Oncogene and Therapeutic Target, Germ Cell-Specific Gene 2 (GSG2), Plays Complex Roles in Promoting Malignant Progression of Gliom
Author: Niu, Zihui; Hou, Shiqiang; Sun, Zhiming; Wang, Zihao; Wang, Jing; Wang, Chao; Zhang, Kang; Wang, Jiajun; Zhang, Chao; Shi, Xingjie; Lin, Ning; Zhang, Lanlan

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096460851260218062401
6、Methyl-β-Cyclodextrin Enhances the Chemotherapeutic Efficacy of Paclitaxel in Breast Cancer Cell
Author: Jin, Haili; Zhou, Liping; Lin, Tianzhen; Chen, Wenbin; Yang, Ruhui

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096430730260120060026
7、Immunotherapy with Chemotherapy in Recurrent or Metastatic Maxillary Sinus Squamous Cell Carcinoma: A Real-world Study in Chin
Author: Zhang, Shuyang; Zhao, Jingyang; Shi, Yijun; Zhu, Changyu; Li, Xinyu; Zhang, Weitao; Liu, Heshu; Li, Wei

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096443625260219081015
8、MiR-124-3p Suppresses Glioma Cells Progression by Targeting STAT3/NAMPT and Inhibiting AKT/ERK Signalin
Author: Liu, Yan; Zhao, Wei; Tang, Zhi; Liu, Wenwu; Wang, Lei; Wang, Te

Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096444128260128052644